CS
ONCR

Credit Suisse’s Oncorus, Inc. ONCR Stock Holding History

Credit Suisse’s Portfolio ONCR Stock Details ONCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-11
Closed – – 4453
2022
Q2 		$0 Buy
+11
New +$15 ﹤0.01% 4520

Other funds holding ONCR

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
FI
Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Credit Suisse's ONCR Position: Q3 2022 in Review

Credit Suisse sold out of Oncorus, Inc. (ONCR) in Q3 2022, closing a stake of 11 shares.

Credit Suisse first reported a position in ONCR in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 40 funds tracked by Wall St. Rank hold ONCR as of Q3 2022.

  • Credit Suisse reported no remaining Oncorus, Inc. position as of Q3 2022 after selling out during the quarter.
  • Credit Suisse sold 11 Oncorus, Inc. shares in Q3 2022.
  • Credit Suisse first reported a position in Oncorus, Inc. in Q2 2022 and held it in 1 quarter.
  • Credit Suisse's Oncorus, Inc. position peaked at $0 in Q2 2022.
  • 40 funds tracked by Wall St. Rank held Oncorus, Inc. as of Q3 2022.

Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.